Charles Schwab Investment Management Inc Athersys, Inc Transaction History

Charles Schwab Investment Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $103,596 - $494,961	-575,537 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $18,149 - $32,063	30,249 Added 5.55%	575,537 $349,000
Q3 2021 Nov 16, 2021	BUY	$1.33 - $1.77 $69,644 - $92,684	52,364 Added 10.62%	545,288 $726,000
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $81,378 - $111,967	57,715 Added 13.26%	492,924 $710,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $19,629 - $28,367	12,664 Added 3.0%	435,209 $762,000
Q3 2020 Nov 13, 2020	SELL	$1.91 - $3.08 $34,895 - $56,271	-18,270 Reduced 4.14%	422,545 $824,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $214,531 - $433,418	108,899 Added 32.81%	440,815 $1.22 Million
Q1 2020 May 15, 2020	BUY	$1.17 - $3.0 $8,952 - $22,956	7,652 Added 2.36%	331,916 $996,000
Q4 2019 Feb 07, 2020	SELL	$1.16 - $1.42 $21,783 - $26,666	-18,779 Reduced 5.47%	324,264 $399,000
Q3 2019 Nov 08, 2019	BUY	$1.21 - $1.65 $39,758 - $54,215	32,858 Added 10.59%	343,043 $457,000
Q2 2019 Aug 09, 2019	BUY	$1.39 - $2.03 $97,067 - $141,760	69,833 Added 29.05%	310,185 $522,000
Q1 2019 May 14, 2019	SELL	$1.39 - $1.71 $14,661 - $18,037	-10,548 Reduced 4.2%	240,352 $361,000
Q2 2018 Aug 08, 2018	BUY	$1.76 - $2.79 $148,896 - $236,034	84,600 Added 50.87%	250,900 $495,000
Q1 2018 May 07, 2018	BUY	$1.34 - $2.03 $12,462 - $18,879	9,300 Added 5.92%	166,300 $305,000
Q3 2017 Nov 13, 2017	BUY	$1.5 - $2.55 $235,500 - $400,350	157,000	157,000 $324,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.